Charles Albright
2018
In 2018, Charles Albright earned a total compensation of $2.4M as Chief Scientific Officer at Editas Medicine, a 89% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,823 |
|---|---|
| Option Awards | $1,855,626 |
| Salary | $390,654 |
| Other | $8,796 |
| Total | $2,387,899 |
Albright received $1.9M in option awards, accounting for 78% of the total pay in 2018.
Albright also received $132.8K in non-equity incentive plan, $390.7K in salary and $8.8K in other compensation.
Rankings
In 2018, Charles Albright's compensation ranked 4,870th out of 14,244 executives tracked by ExecPay. In other words, Albright earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,870 out of 14,244 | 66th |
Division Manufacturing | 1,827 out of 5,759 | 68th |
Major group Chemicals And Allied Products | 666 out of 2,122 | 69th |
Industry group Drugs | 559 out of 1,811 | 69th |
Industry Biological Products, Except Diagnostic Substances | 113 out of 339 | 67th |
Source: SEC filing on April 26, 2019.
Albright's colleagues
We found four more compensation records of executives who worked with Charles Albright at Editas Medicine in 2018.